Dual Thrombolytic Therapy With Mutant Pro-urokinase and Low Dose Alteplase for Ischemic Stroke

Condition:   Ischemic Stroke Interventions:   Drug: mutant pro-urokinase;   Drug: Alteplase Sponsor:   Erasmus Medical Center Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials